Cantor Fitzgerald Keeps Their Buy Rating on ARS Pharmaceuticals (SPRY)
at www.tipranks.com (Fri, 6-Nov 9:52 AM)
ARS Pharmaceuticals GAAP EPS of -$0.36 misses by $0.04, revenue of $37.7M misses by $4.29M
at seekingalpha.com (Thu, 5-Nov 4:07 PM)
